Validation for SaaS LIMS, advance analytics, and cybersecurity features announced during Pittcon virtual press conference.
LabVantage Solutions announced three enhancements to its laboratory information management systems (LIMS) offerings in a virtual press conference on March 8, 2021, part of Pittcon 2021.
The company has added validation to three of its subscription-based software-as-a-service (SaaS) LIMS for regulated sectors, including the pharmaceutical industry. LabVantage Pharma, LabVantage Biobanking, and LabVantage COVID-19 LIMS now offer SaaS validation.
Evidence of validated control provides a record that the software is held to a set standard for data integrity and control and the responsibility rests with the vendor.
Customers pay an annual subscription fee to access the LabVantage LIMS, electronic laboratory notebook, laboratory execution system, and scientific data management system. Validated software updates are implemented by the company. A vendor-validated SaaS LIMS allows customers to expand the system to other locations, subsidiaries, and partners, the company reported.
The company also announced the launch of LabVantage Analytics, a self-service advanced analytics solution that allows users to explore, analyze, and visualize LIMS, enterprise, and external data for business insights. The offering integrates with the LabVantage LIMS platform
LabVantage Analytics enables laboratory managers and business colleagues both inside and outside the lab control of LIMS data together with relevant business and external data.
The tool analyzes structured and unstructured data from different sources, combining data ingestion, pre-processing, storage, analysis, and visualization into one application. Customizable dashboards and LIMS data reports enable users to access needed information.
In a third announcement, the company reported that LabVantage LIMS 8.6 has been designed and tested to optimum cybersecurity standards. The company has adopted SonarQube to scan source code for potential vulnerabilities; the use of Atlassian’s Jira software to track code and increase the visibility of security issues during development; and partnering with a third-party cybersecurity organization to test the software.
LabVantage LIMS features configurable security protocols and permissions that meet the requirements of the US Health Insurance Portability and Accountability Act, and the EU’s General Data Protection Regulation. Encryption is included in multiple stages and the company reports that it has been proactive in ensuring security through penetration testing and other activities to combat cyberattacks.
Source: LabVantage
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.